Sunday, June 14, 2026

Latest

AMD: Analysts Call For Q2 Revenues Of $6.55 Billion

Advanced Micro Devices (NASDAQ: AMD) will be reporting its second quarter financial results today after market close. Analysts have a consensus $128.11 12-month price target on the company, via a total of 42 analysts, with nine analysts having strong buy ratings.

19 analysts meanwhile have buy ratings, 13 analysts have hold ratings and a single analyst has a sell rating on the stock. The street high comes from Elazar Advisors with a $230 price target, and the lowest target sits at $85.

26 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 26 analysts is $6.55 billion; this number has been revised upwards since the start of the year. The highest revenue estimate is $6.7 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently only 4 analysts who have second-quarter EBITDA estimates. The mean is currently $2.1 billion. The estimate has been revised lower since the start of the year. Street high is a $2.1 billion EBITDA estimate, and the lowest is $2 billion.

Analysts estimate that quarterly earnings per share will come in at $1.03, up from the $0.78 estimate at the start of the year. The street high estimate is $1.16, and the lowest estimate is $0.97 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Canadian Dream Is Leaving Canada | Spencer Gatten

Allied Gold: The Zijin Deal Is On The Rocks

Why Silver’s Drop May Not Mean the Bull Market Is Over | Peter Krauth

Recommended

Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project

Blue Jay Gold Launches 16,000 Metre Drill Program At Steller

Related News

Else Nutrition: Canaccord Cuts Price Target After Another Quarter Of Estimate Misses

On November 29th Else Nutrition (TSXV: BABY) announced its third quarter financial results. The company...

Monday, December 6, 2021, 10:20:00 AM

Valens Company: Analysts Downgrade Company Following Reduced Guidance

The Valens Company (TSX: VLNS) experienced a pretty wild second half of January, and analysts...

Monday, February 1, 2021, 02:39:00 PM

Facebook Blows Analyst Expectations Away With Strong Results

Facebook Inc (NASDAQ: FB) opened 8% higher Thursday morning, reaching record highs and closing in...

Saturday, May 1, 2021, 03:34:00 PM

Enthusiast Gaming Sees Canaccord Give Slight Lift To Price Target

On May 16th, Enthusiast Gaming (TSX: EGLX) reported its first quarter financial results. The company...

Sunday, May 22, 2022, 05:19:00 PM

Mind Medicine: Canaccord Genuity Initiates Coverage With C$1.75 Price Target

Yesterday, Canaccord initiated coverage on Mind Medicine (NEO: MMED) with a Speculative Buy rating and...

Wednesday, September 16, 2020, 04:15:00 PM